Filing Details
- Accession Number:
- 0001104659-23-125054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-11 17:25:09
- Reporting Period:
- 2023-12-07
- Accepted Time:
- 2023-12-11 17:25:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1722964 | Y-Mabs Therapeutics Inc. | YMAB | Pharmaceutical Preparations (2834) | 474619612 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1753185 | Johan Wedell-Wedellsborg | C/O Y-Mabs Therapeutics, Inc. 230 Park Avenue, Suite 3350 New York NY 10169 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-07 | 6,183 | $6.50 | 4,431,412 | No | 4 | P | Indirect | By WG Biotech ApS |
| Common Stock | Acquisiton | 2023-12-08 | 18,503 | $6.99 | 4,449,915 | No | 4 | P | Indirect | By WG Biotech ApS |
| Common Stock | Acquisiton | 2023-12-11 | 102,863 | $7.01 | 4,552,778 | No | 4 | P | Indirect | By WG Biotech ApS |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By WG Biotech ApS |
| No | 4 | P | Indirect | By WG Biotech ApS |
| No | 4 | P | Indirect | By WG Biotech ApS |
Footnotes
- This transaction was executed in multiple trades each at price of $6.50. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $6.90 to $7.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $6.86 to $7.15. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.
Billionaire Hedge Funds
